Skip to content
Screener

PTC Therapeutics PTCT Gross margin

Discontinued — last reported Q4 '19

Gross margin at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
76.1%-3.4pp
ALN
Alnylam PharmaceuticalsALNY
79.8%-4.1pp
Biogen logo
BiogenBIIB
74%-1.4pp
uniQure logo
uniQureQURE
92.5%+4.6pp

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$5.78B+41.9%
Enterprise value$5.34B+54.9%
P/E7.1×—
P/S7×+4.7×

Profitability

See full
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%—
Debt / equity372.3×—
Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

gross profit/total revenue=96%

Based on trailing twelve months.

The source filing: PTC Therapeutics’s 10-K, filed February 25, 2021. Open the filing →

Filed
Feb 25, 2021, 4:37 PM EST
Fiscal year
FY2020
Accession
0001070081-21-000009

FAQ

What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.